NCT06694597View on ClinicalTrials.gov

Efficacy, Safety of Astragalus Membranaceus in Mild-to-Moderate Alzheimer's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

May 1, 2023

Primary Completion Date

March 31, 2024

Study Completion Date

March 31, 2024

Conditions
Alzheimer Disease
Interventions
DRUG

Astragalus Membranaceus Root

Astragalus tablets 15g, warm water to drink, once a day, take for 1 year, during which routine treatment should also be carried out.

Trial Locations (1)

350000

Fujian Medical University Union Hospital, Fuzhou

All Listed Sponsors
lead

Fujian Medical University Union Hospital

OTHER

NCT06694597 - Efficacy, Safety of Astragalus Membranaceus in Mild-to-Moderate Alzheimer's Disease | Biotech Hunter | Biotech Hunter